Clinical Study
Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life
Table 5
Evaluation of treatment satisfaction.
| 1Totally Agree, 2Agree a lot, 3Agree, 4Disagree, 5Disagree a lot, 6Totally disagree | ( ) |
| 1. GLP-2 allows me to do, what I please to do. | | 2. I would definitely recommend the GLP-2 medication to others who share my symptoms. | | 3. I am not satisfied with the medication I current receive for my symptoms. | | 4. I am satisfied with the rapid onset of action of GLP-2. | | 5. I feel, that GLP-2 is the best medication available on the market for me. | | 6. I am satisfied with the GLP-2 medication that I have received for my symptoms. | | 7. The medication enables med to eat and drink whatever I please. | |
|
|